nature's bounty alpha lipoic acid & acetyl l carnitine L-Carnitine 400 mg with 200 mg, 120 Capsules (66088) Nature's Bounty Super Alpha Lipoic

In a phase 2, multicenter, randomized, placebo controlled double blind study, crizanlizumab with or without hydroxyurea (SUSTAIN study) (ClinicalTrails.gov Identifier: NCT01895361) showed that patients on the treatment arm had significantly lower rate of sickle-related pain crises compared to placebo with a lower incidence of adverse events - 10% of patients suffered from moderate side effects while one patient suffered from an intracranial bleed during treatment with this drug that could also interfere with platelet function via its effects on selectins ( Post hoc analyses showed that more patients were VOC event-free in the crizanlizumab arm than in the placebo arm, and that crizanlizumab also significantly increased time-to-first VOC compared to the placebo (ClinicalTrials.gov Identifier: NCT03814716)

Someya et al

M., Rowsby, L

They come in different protocols for various patients

Available variations include: 3ML BAC Water 10ML BAC Water These multiple size options provide flexibility for different research requirements and laboratory workflows